Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs

Host-defense peptides (HDPs) have an important therapeutic potential against microbial infections but their metabolic instability and cellular cytotoxicity have limited their utility. To overcome these limitations, we utilized five small-molecule, nonpeptide HDP mimetics (smHDPMs) and tested their effects on cytotoxicity, antimicrobial activity, and mast cell (MC) degranulation. None of the smHDPMs displayed cytotoxicity against mouse 3T3 fibroblasts or human transformed liver HepG2 cells. However, one compound had both antifungal and antibacterial activity. Surprisingly, all five compounds induced degranulation in a human MC line, LAD2, and this response was substantially reduced in Mas-related G protein-coupled receptor (GPCR)-X2 (MRGPRX2)-silenced cells. Furthermore, all five compounds induced degranulation in RBL-2H3 cells expressing MRGPRX2 but this response was abolished in cells expressing naturally occurring loss-of-function missense variants G165E (rs141744602) and D184H (rs372988289). Mrgprb2 is the likely mouse ortholog of human MRGPRX2, which is expressed in connective tissue MCs (CTMCs) such as cutaneous and peritoneal MCs (PMCs). All five smHDPMs induced degranulation in wild-type PMCs but not in cells derived from Mrgprb2−/− mice. These findings suggest that smHDPMs could serve as novel targets for the treatment of drug-resistant fungal and bacterial infections because of their ability to harness CTMCs’ host defense functions.

[1]  E. Lee,et al.  Inhibitory Effects of AF-343, a Mixture of Cassia tora L., Ulmus pumila L., and Taraxacum officinale, on Compound 48/80-Mediated Allergic Responses in RBL-2H3 Cells , 2020, Molecules.

[2]  Y. Okuno,et al.  Suppression of IgE-Independent Degranulation of Murine Connective Tissue-Type Mast Cells by Dexamethasone , 2019, Cells.

[3]  M. Arifuzzaman,et al.  MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection , 2019, Science Advances.

[4]  K. Gupta,et al.  Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant , 2018, The Journal of Immunology.

[5]  Guoming Chen,et al.  Mast Cell Activation Protects Cornea by Promoting Neutrophil Infiltration via Stimulating ICAM-1 and Vascular Dilation in Fungal Keratitis , 2018, Scientific Reports.

[6]  L. Romani,et al.  The contribution of mast cells to bacterial and fungal infection immunity , 2018, Immunological reviews.

[7]  R. Panettieri,et al.  Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1 , 2018, Respiratory Research.

[8]  T. Zuberbier,et al.  Allergic FcεRI‐ and pseudo‐allergic MRGPRX2‐triggered mast cell activation routes are independent and inversely regulated by SCF , 2018, Allergy.

[9]  M. Colombo,et al.  Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses. , 2017, Trends in immunology.

[10]  H. Subramanian,et al.  Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide , 2017, Infection and Immunity.

[11]  K. Freeman,et al.  Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism , 2017, Scientific Reports.

[12]  M. Mahlapuu,et al.  Antimicrobial Peptides: An Emerging Category of Therapeutic Agents , 2016, Front. Cell. Infect. Microbiol..

[13]  G. Tew,et al.  Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications. , 2016, Current topics in medicinal chemistry.

[14]  A. Regev,et al.  Expression profiling of constitutive mast cells reveals a unique identity within the immune system , 2016, Nature Immunology.

[15]  S. Abraham,et al.  IL-27 Facilitates Skin Wound Healing through Induction of Epidermal Proliferation and Host Defense , 2016, The Journal of investigative dermatology.

[16]  E. Romanowski,et al.  An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-infective. , 2016, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[17]  H. Subramanian,et al.  Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties , 2015, Oncotarget.

[18]  Xinzhong Dong,et al.  Identification of a mast cell specific receptor crucial for pseudo-allergic drug reactions , 2014, Nature.

[19]  K. Austen,et al.  Maturation of mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation in mice , 2014, Mucosal Immunology.

[20]  H. Kita,et al.  Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. , 2014, The Journal of allergy and clinical immunology.

[21]  K. Freeman,et al.  Activity of Potent and Selective Host Defense Peptide Mimetics in Mouse Models of Oral Candidiasis , 2014, Antimicrobial Agents and Chemotherapy.

[22]  Antibiotic resistance—the need for global solutions , 2014, BDJ.

[23]  H. Subramanian,et al.  β-Defensins Activate Human Mast Cells via Mas-Related Gene X2 , 2013, The Journal of Immunology.

[24]  N. Yoshino,et al.  Polymyxins as Novel and Safe Mucosal Adjuvants to Induce Humoral Immune Responses in Mice , 2013, PloS one.

[25]  P. Thomas,et al.  Mycotic keratitis: epidemiology, diagnosis and management. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  M. Maurer,et al.  Role and Relevance of Mast Cells in Fungal Infections , 2012, Front. Immun..

[27]  H. Subramanian,et al.  Mas-related Gene X2 (MrgX2) Is a Novel G Protein-coupled Receptor for the Antimicrobial Peptide LL-37 in Human Mast Cells , 2011, The Journal of Biological Chemistry.

[28]  D. McAuley,et al.  Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo , 2011, PloS one.

[29]  M. Bassetti,et al.  Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy , 2011, PloS one.

[30]  G. S. de Hoog,et al.  Black yeast‐like fungi in skin and nail: it probably matters , 2011, Mycoses.

[31]  G. Diamond,et al.  Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity. , 2010, Molecular oral microbiology.

[32]  G. Diamond,et al.  Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans. , 2010, Molecular oral microbiology.

[33]  J. Colin,et al.  In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. , 2010, Investigative ophthalmology & visual science.

[34]  F. Finkelman,et al.  Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism , 2009, Proceedings of the National Academy of Sciences.

[35]  C. Shimbori,et al.  Pathophysiological Role of Skin Mast Cells in Wound Healing after Scald Injury: Study with Mast Cell-Deficient W/WV Mice , 2009, International Archives of Allergy and Immunology.

[36]  Aaron Weinberg,et al.  The roles of antimicrobial peptides in innate host defense. , 2009, Current pharmaceutical design.

[37]  T. Zuberbier,et al.  Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands , 2009, Experimental dermatology.

[38]  W. DeGrado,et al.  De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers , 2009, Proceedings of the National Academy of Sciences.

[39]  M. Spielmann,et al.  Human beta‐defensin‐3 promotes wound healing in infected diabetic wounds , 2009, The journal of gene medicine.

[40]  C. Putensen,et al.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment , 2009, Intensive Care Medicine.

[41]  A. Di Nardo,et al.  Mast Cell Cathelicidin Antimicrobial Peptide Prevents Invasive Group A Streptococcus Infection of the Skin1 , 2008, The Journal of Immunology.

[42]  G. Tew,et al.  Activity of an Antimicrobial Peptide Mimetic against Planktonic and Biofilm Cultures of Oral Pathogens , 2007, Antimicrobial Agents and Chemotherapy.

[43]  S. Thakurdas,et al.  The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections* , 2007, Journal of Biological Chemistry.

[44]  D. Metcalfe,et al.  Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. , 2003, Leukemia research.

[45]  S. Zahler,et al.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.

[46]  A. Vitiello,et al.  Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.

[47]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[48]  Y. Shai.  From innate immunity to de-novo designed antimicrobial peptides. , 2002, Current pharmaceutical design.

[49]  R. Hancock,et al.  Synergistic Interactions between Mammalian Antimicrobial Defense Peptides , 2001, Antimicrobial Agents and Chemotherapy.

[50]  R. Hancock,et al.  The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.

[51]  S. Abraham,et al.  Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis , 2000, Journal of leukocyte biology.

[52]  J. Fiddes,et al.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity , 1997, Antimicrobial agents and chemotherapy.

[53]  B. Echtenacher,et al.  Critical protective role of mast cells in a model of acute septic peritonitis , 1996, Nature.

[54]  R. Snyderman,et al.  Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. , 1994, The Journal of biological chemistry.

[55]  C. Elson,et al.  Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. , 1987, Journal of immunology.

[56]  L. Schwartz,et al.  Two types of human mast cells that have distinct neutral protease compositions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Krisztina V. Vukman,et al.  Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation , 2011, Inflammation Research.

[58]  L. Romani.  Immunity to fungal infections , 2011, Nature Reviews Immunology.

[59]  C. Putensen,et al.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis , 2008, Intensive Care Medicine.